sanofi aventis

Welcome to the 'sanofi aventis' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'sanofi aventis'.

Latest blogosphere posts tagged “sanofi aventis”

• Top Picks for 2010: ImmunoGen (IMGN)

  
  BloggingStocks — Authority: 673
  Filed under: Newsletters , Stocks to Buy , best stocks for 2010 This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nations leading advisors for their single favorite stock for the new year. See all 80 stocks listed here . "Our ...
  4 days ago

• Pharmalot… Pharmalittle… Slowing Down Yet?

  
  Pharmalot — Authority: 548
  A long holiday weekend may be in the offing, but the Pharmalot corporate campus is still humming. And why not? The world has not stopped spinning, after all, and thhere is always something interesting going on. So while you prepare for the holiday or simply slow down the usual pace, here are a few items to help you ...
  6 days ago

• Michael Aiello: The M.&A. Lawyer Who Doesnt Sleep

  
  DealBook — Authority: 777
  Michael Aiello is on fire. The young mergers and acquisition partner at Weil Gotshal & Manges has had a hand in three high profile public deals for three high profile clients in the last seven days.
  1 week ago

• ($SNY) Sanofi-Aventis Expands Presence in U.S. by Aquiring Chattem

  
  Stock Blog Hub — Authority: 465
  Sanofi-Aventis ( SNY ) has decided to acquire U.S.-based Chattem Inc. ( CHTT ) for $93.50 per share, or approximately $1.9 billion, to create the world’s fifth-largest consumer healthcare company. The offered price represents a 34% premium over Chattem’s Dec. 18th closing price. Currently many pharma players ...
  1 week ago

• Sanofi-Aventis to buy Chattem

  
  FT Alphaville — Authority: 694
  Sanofi-Aventis, the French pharmaceuticals group, has agreed to buy Chattem, a US consumer healthcare company, in a $1.9bn cash deal that will hasten its diversification away from prescription medicines. Sanofi will pay $93.50 a share for Chattem, pushing Sanofi from the sixth to the world’s fifth largest consumer ...
  1 week ago

• Sanofi-Aventis Buys Chattem for $1.9 Billion

  
  Business Finance & Economy - business.marc8.com — Authority: 165
  The French drug maker Sanofi-Aventis said Monday that it had agreed to buy the consumer health care company Chattem for about $1.9 billion, in a deal which will give Sanofi an over-the-counter presence in the United States.
  1 week ago

• Sanofi-Chattem: Another Bet on the Global Consumer – Wall Street Journal (blog)

  
  Memmis.com News Agency — Authority: 174
  Globe and Mail Sanofi- Chattem : Another Bet on the Global Consumer Wall Street Journal (blog) Sanofi-Aventis $1.9 billion bid for Chattem , the maker of foot power and antidandruff shampoo, signals another large company with a ... Sanofi Boosts Consumer Drugs Portfolio With Chattem Buy ...
  1 week ago

• Sanofi-Aventis Buys Chattem, a Leader in Over-the-Counter Sales

  
  DailyFinance — Authority: 768
  Sanofi-Aventis ( SNY ) announced Monday it will acquire Chattem Inc. ( CHTT ) for about $1.9 billion -- paying $93.50 per share, a 34% premium over Chattems closing price Friday. The deal will create the worlds fifth-largest consumer health-care company by revenues and helps the French drugmaker diversify into ...
  1 week ago

• Sanofi to acquire Chattem of the US for $1.9bn

  
  FT Alphaville — Authority: 694
  Here’s something unseasonal: an M&A announcement coming out of Paris and Chattanooga, Tennessee, days before Xmas. Sanofi-Aventis is paying $1.9bn in cash, or $93.50 per share, for Chattem, a decidedly consumer-facing business which has been producing toiletries, creams and dietary supplements for 130 years....
  1 week ago

• Sanofi-Aventis Buys Chattem, Countering Patent Cliff Losses

  
  Business Pundit — Authority: 610
  Sanofi-Aventis (SAN.FR), one of the world’s largest prescription drug companies by sales, bought Tenn.-based Chattem (CHTT) , which makes products like Gold Bond, Selsun Blue and Icy Hot, for about $1.9 billion in cash (this is $93.50/share). The Wall Street Journal has more : Seeking to offset the impending ...
  1 week ago

• Sanofi-Aventis Buys Chattem for $1.9 Billion

  
  NYT > Theater — Authority: 904
  The deal for the consumer health care group will give Sanofi an over-the-counter presence in the United States.
  1 week ago

• Sanofi-Aventis to Buy Chattem for $1.9 Billion (SNY)

  
  Dividend Stocks - The Dividend Daily — Authority: 496
  French pharmaceutical group Sanofi-Aventis SA ( SNY ) said Monday that it will buy over-the-counter drugmaker Chattem Inc. ( CHTT ) for $1.9 billion. The company will pay $93.50 in cash for each share of Chattem, which represents a 34% premium over the stock’s Friday’s closing price. Chattem, which is ...
  1 week ago

• Sanofi-Aventis Buying Chattem for $1.9 Billion

  
  DealBook — Authority: 777
  Sanofi-Aventis said Monday that it has agreed to acquire Chattem for $1.9 billion in cash, or $93.50 a share.
  1 week ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 548
  Welcome to the working week. We hope your weekend was pleasant, although there was a great deal of shoveling in some parts. Good exercise, yes? Meanwhile, this is a short week for many due to the pending holiday. Nonetheless, this means a flurry of year-end deadlines and meetings. So as you brace yourself for the ...
  1 week ago

• Sanofi Sales Rep Sues For Overtime Pay

  
  Pharmalot — Authority: 548
  Yet another sales rep has joined the battle about overtime pay. The latest involves a Sanofi-Aventis rep in Minnesota, Dede Evavold, who alleges in a putative class action lawsuit ( see here ) that she and others were denied overtime pay in violation of federal law. Typically, sales reps argue they are not exempt from ...
  1 week ago

• (AMLN) Amylin Pharmaceuticals Impresses in Head-to-Head

  
  Stock Blog Hub — Authority: 465
  Amylin Pharmaceuticals, Inc. ( AMLN ) recently announced positive results on its once weekly formulation of Byetta (referred to as exenatide once weekly), which is being developed in collaboration with Eli Lilly and Company ( LLY ) and Alkermes, Inc. ( ALKS ). Amylin presented results from a head-to-head study ...
  1 week ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 548
  Rise and shine, everyone, another day has begun. And as the Morning Mayor used to say, every brand new day should be unwrapped like a precious gift. As you can tell, we like comforting thoughts. So as you unwrap your proverbial ribbon, we have assembled a few items to help you along. Whatever you do today, we hope you ...
  2 weeks ago

• Recall: 800,000 Doses of Swine flu Vaccine

  
  Kreuzer's Korner — Authority: 137
  Sanofi-Aventis is recalling 800,000 doses of H1N1 vaccine meant for children younger than 3 because the vaccine has lost potency. Hmmm… From CNN : The French manufacturer Sanofi Pasteur is voluntarily recalling about 800,000 doses of vaccine meant for children between the ages of 6 months and 35 months. ...
  2 weeks ago

• State received recalled H1N1 vaccine

  
  Michigan Messenger — Authority: 606
  The Michigan Department of Community Health announced Tuesday some state children may have been vaccinated against influenza A (H1N1) with vaccine from a recalled lot. Sanofi-Aventis SA, maker of the vaccine, recalled 800,000 pediatric doses, a press release from MDCH notes, because “tests found the potency was ...
  2 weeks ago

• 800,000 Swine Flu Vaccines Recalled Due to Fading Potency

  
  Wall Street Pit — Authority: 665
  Health officials have recalled 800,000 doses of swine flu vaccine for children because tests indicate the vaccine doses lost some strength and may not be potent enough to protect against the virus, federal officials said today.The Centers for Disease Control and Prevention issued an alert about...
  2 weeks ago

Comments about sanofi aventis